Full Text

Turn on search term navigation

Copyright © 2023 Brian Godman et al. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. https://creativecommons.org/licenses/by/4.0/

Details

Title
Corrigendum to “Utilisation Trend of Long-Acting Insulin Analogues including Biosimilars across Europe: Findings and Implications”
Author
Godman, Brian 1 ; Wladysiuk, Magdalene 2 ; McTaggart, Stuart 3 ; Kurdi, Amanj 4 ; Allocati, Eleonora 5 ; Jakovljevic, Mihajlo 6   VIAFID ORCID Logo  ; Kalemeera, Francis 7 ; Hoxha, Iris 8 ; Nachtnebel, Anna 9 ; Sauermann, Robert 9 ; Hinteregger, Manfred 9 ; Marković-Peković, Vanda 10   VIAFID ORCID Logo  ; Tubic, Biljana 11 ; Petrova, Guenka 12   VIAFID ORCID Logo  ; Tachkov, Konstantin 12 ; Slabý, Juraj 13 ; Nejezchlebova, Radka 13 ; Iva Selke Krulichová 14 ; Ott Laius 15 ; Selke, Gisbert 16 ; Langner, Irene 16 ; Harsanyi, András 17 ; Inotai, András 18   VIAFID ORCID Logo  ; Jakupi, Arianit 19   VIAFID ORCID Logo  ; Svens Henkuzens 20 ; Garuolienė, Kristina 21   VIAFID ORCID Logo  ; Gulbinovič, Jolanta 21   VIAFID ORCID Logo  ; Patricia Vella Bonanno 22 ; Rutkowski, Jakub 23 ; Skule Ingeberg 24 ; Melien, Øyvind 24 ; Mardare, Ileana 25 ; Fürst, Jurij 26 ; MacBride-Stewart, Sean 27 ; Holmes, Carol 28 ; Pontes, Caridad 29 ; Zara, Corinne 30 ; Marta Turu Pedrola 30 ; Hoffmann, Mikael 31 ; Kourafalos, Vasileios 32 ; Pisana, Alice 33   VIAFID ORCID Logo  ; Banzi, Rita 5   VIAFID ORCID Logo  ; Campbell, Stephen 34   VIAFID ORCID Logo  ; Wettermark, Bjorn 35 

 Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow G4 0RE, UK; Division of Public Health Pharmacy and Management, School of Pharmacy, Sefako Makgatho Health Sciences University, Pretoria, South Africa; School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang, Malaysia 
 Chair of Epidemiology and Preventive Medicine, Medical College, Jagiellonian University, Krakow, Poland; HTA Consulting, Starowiślna Str. 17/3, 31-038 Krakow, Poland 
 Public Health Scotland, Gyle Square, 1 South Gyle Crescent, Edinburgh, UK 
 Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow G4 0RE, UK; Division of Public Health Pharmacy and Management, School of Pharmacy, Sefako Makgatho Health Sciences University, Pretoria, South Africa; Department of Pharmacology, College of Pharmacy, Hawler Medical University, Erbil, Iraq 
 Istituto di Ricerche Farmacologiche “Mario Negri” IRCCS, Milan, Italy 
 Institute of Advanced Manufacturing Technologies, Peter the Great St. Petersburg Polytechnic University, St. Petersburg, Russia; Institute of Comparative Economic Studies, Hosei University Tokyo, Japan; Department of Global Health Economics and Policy, University of Kragujevac, Serbia 
 Department of Pharmacy Practice and Policy, Faculty of Health Sciences, University of Namibia, Windhoek, Namibia 
 Department of Pharmacy, Faculty of Medicine, University of Medicine, Tirana, Albania 
 Dachverband der Österreichischen Sozialversicherungen, Kundmanngasse 21, AT-1030 Vienna, Austria 
10  Faculty of Medicine, Department of Social Pharmacy, University of Banja Luka, Banja Luka, Bosnia and Herzegovina 
11  Faculty of Medicine, Department of Medicinal Chemistry, University of Banja Luka, Banja Luka, Bosnia and Herzegovina; Agency for Medicinal Product and Medical Devices of Bosnia and Herzegovina, 78000 Banja Luka, Bosnia and Herzegovina 
12  Faculty of Pharmacy, Department of Social Pharmacy and Pharmacoeconomics, Medical University of Sofia, Sofia, Bulgaria 
13  State Institute for Drug Control, Prague, Czech Republic 
14  Department of Medical Biophysics, Faculty of Medicine in Hradec Králové, Charles University, Simkova 870, 500 03 Hradec Králové, Czech Republic 
15  State Agency of Medicines, Nooruse 1, 50411 Tartu, Estonia 
16  Wissenschaftliches Institut der AOK (WIdO), Rosenthaler Straße 31, 10178 Berlin, Germany 
17  Department of Health Policy and Health Economics, Eotvos Lorand University, Budapest, Hungary 
18  Syreon Research Institute and Semmelweis University, Center of Health Technology Assessment, Budapest, Hungary 
19  Faculty of Pharmacy, UBT Higher Education Institute, Pristina, Kosovo 
20  Independent Consultant, Riga, Latvia 
21  Department of Pathology, Forensic Medicine and Pharmacology, Institute of Biomedical Sciences, Faculty of Medicine, Vilnius University, Vilnius, Lithuania 
22  Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow G4 0RE, UK; Department of Health Services Management, University of Malta, Valletta, Malta 
23  HTA Consulting, Starowiślna Str. 17/3, 31-038 Krakow, Poland 
24  Medicines Committee, Oslo University Hospitals, Oslo, Norway 
25  Faculty of Medicine, Public Health and Management Department, “Carol Davila” University of Medicine and Pharmacy Bucharest, 050463 Bucharest, Romania 
26  Health Insurance Institute, Miklosiceva 24, SI-1507 Ljubljana, Slovenia 
27  Pharmacy Services, Greater Glasgow and Clyde (NHS GGC), Glasgow, UK 
28  NHS Lothian, Edinburgh, UK 
29  Drug Department, Catalan Health Service, Gran Via de les Corts Catalanes, 08007 Barcelona, Spain; Department of Pharmacology, Therapeutics and Toxicology, Universitat Autònoma de Barcelona, Barcelona, Spain 
30  Drug Department, Catalan Health Service, Gran Via de les Corts Catalanes, 08007 Barcelona, Spain 
31  NEPI-Nätverk för Läkemedelsepidemiologi, Stockholm, Sweden 
32  National Organization for the Provision of Healthcare Services (EOPYY), Athens, Greece 
33  Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden 
34  Centre for Primary Care and Health Services Research, School of Health Sciences, University of Manchester, Manchester M13 9PL, UK; NIHR Greater Manchester Patient Safety Translational Research Centre, School of Health Sciences, University of Manchester, Manchester, UK 
35  Department of Pharmacy, Disciplinary Domain of Medicine and Pharmacy, Uppsala University, Uppsala, Sweden 
Publication year
2023
Publication date
2023
Publisher
John Wiley & Sons, Inc.
ISSN
23146133
e-ISSN
23146141
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2801794166
Copyright
Copyright © 2023 Brian Godman et al. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. https://creativecommons.org/licenses/by/4.0/